Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/131
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMaycock, E. J.en
dc.contributor.authorThe, R. I. H.en
dc.contributor.authorNicholls, K. A.en
dc.contributor.authorRose, M. A.en
dc.contributor.authorScolaro, R. J.en
dc.contributor.authorThe, Rihen
dc.contributor.authorCrilly, H. M.en
dc.contributor.authorMcAleer, P. T.en
dc.date.accessioned2018-06-16T20:29:54Z-
dc.date.available2018-06-16T20:29:54Z-
dc.date.issued2017en
dc.identifier.citation45, (5), 2017, p. 543-555en
dc.identifier.otherRISen
dc.identifier.urihttp://dora.health.qld.gov.au/qldresearchjspui/handle/1/131-
dc.description.abstractThese guidelines are a consensus document developed by a working party of the Australian and New Zealand Anaesthetic Allergy Group (ANZAAG) to provide an approach to the investigation of perioperative anaphylaxis. They focus primarily on the use of skin testing as it is the investigation with the greatest clinical utility for the identification of the likely causative agent and potentially safer alternatives. The practicalities and process of skin testing, its limitations, and the place of other tests are discussed. These guidelines also address the roles of graded challenge and in vitro testing. The implications of anaphylaxis associated with neuromuscular blocking agents, beta-lactam antibiotics, local anaesthetic agents and chlorhexidine are discussed. Evidence for the recommendations is derived from literature searches using the words skin test, allergy, anaphylaxis, anaesthesia, and each of the individual agents listed in these guidelines. The individual articles were then reviewed for suitability for inclusion in these guidelines. Where evidence was not strong, as is the situation for many perioperative agents, expert consensus from the ANZAAG working party was used. These guidelines are intended for use by specialists involved in the investigation of perioperative allergy. They have been approved following peer review by members of ANZAAG and are available on the ANZAAG website: http://www.anzaag.com/anaphylaxis-management/testing-guidelines.pdf.practice guidelines. Journal Subset: Australia & New Zealand; Biomedical; Peer Reviewed. Instrumentation: Clinical Decision Making in Nursing Scale (CDMNS) (Jenkins). NLM UID: 0342017.PMID: 28911283. <br />en
dc.languageenen
dc.relation.ispartofAnaesthesia & Intensive Careen
dc.titleAustralian and New Zealand Anaesthetic Allergy Group Perioperative Anaphylaxis Investigation Guidelinesen
dc.typeArticleen
dc.subject.keywordsAnesthetics -- Adverse EffectsDrug Hypersensitivity -- Prevention and Controlen
dc.subject.keywordsAnaphylaxis -- Prevention and Controlen
dc.subject.keywordsDrug Hypersensitivity -- Etiologyen
dc.subject.keywordsSkin Tests -- Methodsen
dc.subject.keywordsAnesthetics -- Administration and Dosageen
dc.subject.keywordsAustraliaen
dc.subject.keywordsDrug Hypersensitivity -- Diagnosisen
dc.subject.keywordsIntraoperative Perioden
dc.subject.keywordsAnaphylaxis -- Etiologyen
dc.subject.keywordsNew Zealanden
dc.subject.keywordsScalesen
dc.relation.urlhttp://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,athens&db=ccm&AN=125893028&site=ehost-liveen
dc.identifier.risid1179en
dc.description.pages543-555en
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.openairetypeArticle-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
Appears in Sites:Queensland Health Publications
Sunshine Coast HHS Publications
Show simple item record

Page view(s)

240
checked on May 21, 2026

Google ScholarTM

Check


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.